Ultra Seal Corporation recalls Regular Strength Pain Reliever (acetaminophen 110 mg, aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) 2 tablet pa
Recalled February 9, 2022 · FDA recall D-0498-2022 · Ultra Seal
Hazard
cGMP deviations · FDA Class II
Units
1,180,000 packets
Sold at
Nationwide within the United States
Description
cGMP deviations
Product
Regular Strength Pain Reliever (acetaminophen 110 mg, aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) 2 tablet packets, Mfg for Advanced First Aid, Baltimore, MD 21237, NDC 67060-0113-00
Manufacturer(s)
Ultra Seal Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →